Located in Yunmeng Economic Development Zone in Hubei Province, Hubei Merryclin is a public company listed on Merry clin group, and one of the largest pharmaceutical enterprisse in China. The total investment of entire project is about $ 200 million, total project area of 300 acres, workshop and office building area of approximately 23,000 square meters. Construction project officially started on August 18, 2010 and got the "drug production license" on October 9, 2011 On March 9, 2012, we will complete the production scope changes and in April 2012 We will finish the project construction. It has 12 production lines, and the production of dosage forms include tablets, hard capsules, granules, ointments, creams, oral solution, large volume injection, small volume injection (including the small capacity of the non-terminally sterilized injection), freeze-dried powder injection, raw materials, sterile raw materials, pharmaceutical excipients. The main production equipment, clean area, cleanliness are in line with the new version (2010) the GMP requirements and test facilities are with the self-test capability about production of varieties of raw materials, packaging materials, semi-finished products, finished .The annual production capacity of 20 million of the lyophilized powder for injection, small volume injection of 100 million, large-volume injection of 20 million bottles, 10 million of the oral solution, creams / ointments 30 million, 33 million tablets, hard capsules, 33 million, 33 million bags of granules, sterile 10,000 kg of active pharmaceutical ingredients (cefmenoxime hydrochloride), bulk drugs (oxiracetam Dibazol, lansoprazole, L-ornithine hydrochloride, aspartic acid ornithine, benzene phosphorus thiamine, force in agriculture, linezolid, calcipotriol, iodixanol, fumaric acid for tenofovir fat, quetiapine fumarate, nalmefene hydrochloride, epinephrine bitartrate norepinephrine, Verapamil c adrenaline, isoproterenol sulfate, phenylephrine hydrochloride, a
